Within the combination therapy group, grade 3 or higher TRAEs occurred in three patients (17.6%), including one patient each with elevated alanine aminotransferase or aspartate aminotransferase, pneumonitis, and hypertension. This evidence concerns the gene GPT and pneumonitis.